Lungyen Life Service (5530) fair value: what the stock is really worth
As of Nov 6, 2026: fair value (intrinsic value) of Lungyen Life Service stock TWD 15.88, price TWD 44.50, that is 64.3% below the price, quality 43 out of 100. Rating: strongly overvalued. Calculated from audited financials with 13 of our 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 5, 2026.
How to read this chart
60‑month range 35.20 TWD – 88.10 TWD · fair‑value band 13.49 TWD – 22.13 TWD · the 44.50 TWD price screens above the 15.88 TWD fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 5, 2026.
Follow Lungyen Life Service in your weekly email
Every Wednesday you see whether Lungyen Life Service is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Lungyen Life Service Corporation provides funeral facilities and services in Taiwan. It operates through five segments: Columbarium Sales; Funeral Service; Property Lease; Cemetery Operation and Others; and Construction Sales.
Show moreShow less
The company's funeral services comprise contract and service guide, and order wreath; cemetery services, such as cemetery guide and services, and shuttle services; and pet grooming services.
It is also involved in the development, sale, and rental of residential and commercial buildings; investment and food wholesale business; and the provision of architecture and civil engineering services. The company was formerly known as Da Han Construction.
Lungyen Life Service Corporation was incorporated in 1987 and is based in Taipei City, Taiwan.
Stock analysis
Lungyen Life Service (5530) currently trades at 44.50 TWD, while our model-based Fair Value estimate is 15.88 TWD, 64% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Growth Earnings group reads highest at a median of 45.66 TWD per share, and 4 of the 13 models we run sit above the 44.50 TWD price.
Bear case: the Asset-Based group reads lowest at 2.77 TWD, and 9 of the 13 models stay below the price. Data coverage for this calculation is medium.
Scenario range: 13.49 TWD (bear) to 22.13 TWD (bull), the price of 44.50 TWD sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 43/100 (below-average quality), in the Consumer Cyclical sector.
Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Lungyen Life Service reported revenue of 4.0B TWD in FY2025 versus 3.6B TWD in FY2021, a compound +3.3%/yr. Reported net income was 1.2B TWD in FY2025, compounding −4.9%/yr from FY2021.
Key figures
Market cap 18.7B TWD (≈ $569M) Small · P/E ratio 13.4 · P/S ratio 4.97 · EPS (TTM) 3.33 TWD · Net margin 37.4% · Return on equity 4.9% · Return on assets (EBIT) 1.6% (5-year average) · Operating margin 20.2%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 53 out of 100 (medium confidence).
What moves the price
The share trades about 23% below its 52-week high and 1% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Consumer Cyclical peers we cover trades at 4% fair-value upside, at −64%, 5530 screens richer than that median.
Fair Value models
Bear13.49 TWDFair Value 15.88 TWDBull22.13 TWD
Price 44.50 TWD · Downside -64.3%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2025 figures (about 10 months old). Earnings retained since then (2.86 TWD per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.29/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
−2.7%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+0.7%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+2.0%
Start year 2020 (pandemic)
Revenue growth 8 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−2.9%
’17
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years), in TWD ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in TWD: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
−4.0%
Earnings growth per share plus dividend.
Earnings per share, growth per year−4.0%
Dividend (yield on the price)0.0%
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.40% → 22%
⚠ Revenue per share shrinking 3.1%/yr over ~6Y (margins eroding too) ⓘStructural-decline marker: revenue PER SHARE has fallen over the last decade (robust median trend, not a single year). Backtested across 2005 to 2017, such businesses trailed the market by about 2.5 percentage points per year. Display only: it does not change the fair value or the quality score.
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Personal Services · 38 stocks
Beats the industry median on 4/12 measures
Overall it trails its industry peers.
Valuation
Quality Score43 · Bottom 25%
Fair Value upside−64.3% · Bottom 25%
Profitability
Return on equity (12 months)4.9% · Below median
Return on assets1.5% · Below median
Net margin (12 months)37.4% · Top 25%
Operating margin (12 months)20.2% · Top 25%
Growth and dividend
Revenue growth (quarter YoY)−16.1% · Bottom 25%
Valuation Multiplesvs Personal Services median · lower = cheaper
P/E (12 months)13.4× · Cheaper than median
P/B0.66× · Cheaper than median
P/S (12 months)4.97× · Priciest 25%
EV/EBITDA19.2× · Priciest 25%
PEG9.21× · Priciest 25%
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 48
FUTURE (revenue growth)0· sector 27
PAST (return on equity)19· sector 36
HEALTH (low debt)100· sector 91
DIVIDEND (yield)0· sector 64
VALUE 0: the price sits above our fair-value range.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Lungyen Life Service Fair Value". https://www.fairvalue-calculator.com/stock/5530
Frequently asked questions
Is Lungyen Life Service (5530) overvalued or undervalued?
As of Nov 5, 2026, our model estimates a fair value of 15.88 TWD versus a price of 44.50 TWD, about 64% lower (overvalued).
What is the fair value of 5530?
Our model-based fair value for Lungyen Life Service is 15.88 TWD (as of Nov 5, 2026), built from audited fundamentals. The current price: 44.50 TWD.
What is the quality score of 5530?
Lungyen Life Service has a Quality Score of 43/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Lungyen Life Service (5530)?
Our model-based price target is the fair value of 15.88 TWD (as of Nov 5, 2026) from 13 valuation models. Cautious scenario 13.49 TWD, optimistic scenario 22.13 TWD. It is a calculation from audited fundamentals, not an analyst target.
What is the Lungyen Life Service stock forecast for 2026?
Our models put fair value at 15.88 TWD, about 64% lower versus a price of 44.50 TWD (overvalued). Cautious scenario 13.49 TWD, optimistic scenario 22.13 TWD. The calculation is refreshed regularly with new filings.
What is the revenue of Lungyen Life Service (5530)?
Lungyen Life Service reported trailing-twelve-month revenue of about 3.8B TWD (latest available figure, as of Nov 5, 2026).
What is the intrinsic value of Lungyen Life Service (5530)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Lungyen Life Service it is 15.88 TWD per share (as of Nov 5, 2026), against a price of 44.50 TWD. It is the blended result of 13 valuation models in 6 families (DCF Models, Earnings-Based, Multiples, Asset-Based, Economic Profit, Growth Earnings).
Is Lungyen Life Service stock overvalued or undervalued in 2026?
As of Nov 5, 2026, 5530 trades above its calculated fair value: price 44.50 TWD, fair value 15.88 TWD, a gap of about −64% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 5530?
No. The price is what the market pays today (44.50 TWD); the fair value is what the company's own numbers justify (15.88 TWD). For Lungyen Life Service the two are 28.62 TWD per share apart. That gap is exactly why we show both numbers side by side.
How much is Lungyen Life Service worth?
The market values Lungyen Life Service at about 18.7B TWD (market capitalisation, as of Nov 5, 2026). Per share that is 44.50 TWD; our models calculate a fair value of 15.88 TWD per share.
What do the bullish and bearish scenarios say about 5530?
Our models span a range for Lungyen Life Service: cautious scenario 13.49 TWD, base 15.88 TWD, optimistic 22.13 TWD per share (as of Nov 5, 2026, price 44.50 TWD). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 5530?
Lungyen Life Service trades at a price-to-earnings ratio of 13.4 (as of Nov 5, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of 15.88 TWD is built from several models across several years. Median P/E at fiscal year-end, 9 fiscal years (2017 to 2025), reported earnings: 14.0. Other multiples: PEG 9.2, P/B 0.7, P/S 5.0, EV/EBITDA 19.2.
What is the PEG ratio of 5530?
The PEG ratio of Lungyen Life Service is 9.21 (P/E divided by earnings growth, as of Nov 5, 2026). That is above 1, so the growth is already paid for in the price.
How solid is the balance sheet of Lungyen Life Service (5530)?
Balance-sheet figures for Lungyen Life Service (as of Nov 5, 2026): return on equity 4.9%. They feed the Quality Score of 43/100, which measures business quality independently of the share price.
How far is 5530 from its 52-week high?
Lungyen Life Service trades at 44.50 TWD, about 23% below its 52-week high of 58.00 TWD and 1% above the low of 44.00 TWD (as of Nov 6, 2026). Distance from the high says nothing about value: that is what the fair value of 15.88 TWD is for.
Which stocks are comparable to Lungyen Life Service?
From the same area (Consumer Cyclical) we also value Rollins, Inc, Service Corporation, Frontdoor, Inc, H&R Block, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Lungyen Life Service stock attractive at the current price?
The data as of Nov 5, 2026: price 44.50 TWD, calculated fair value 15.88 TWD (−64%), Quality Score 43/100, from 13 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 5530 calculated?
We run Lungyen Life Service through 13 models from 6 families: DCF Models, Earnings-Based, Multiples, Asset-Based, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of 15.88 TWD builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.3% above its aggregate fair value. Lungyen Life Service itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Lungyen Life Service (5530)?
The closing price on Nov 6, 2026 was 44.50 TWD. Our model-based fair value is 15.88 TWD, about 64% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Lungyen Life Service right now?
The price sits above even our optimistic bull case (22.13 TWD). The favourable scenario is already priced in. Weak quality (43/100) and above fair value at the same time, the margin of safety is missing on both counts.
Key figures of Lungyen Life Service
How large is the market capitalisation of Lungyen Life Service (5530)?
The market capitalisation of Lungyen Life Service is 18.7B TWD (≈ $569M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Lungyen Life Service (5530)?
The price-to-sales ratio of Lungyen Life Service is 4.97 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Lungyen Life Service (5530)?
Earnings per share at Lungyen Life Service are 3.33 TWD (price ÷ EPS = P/E 13.4). Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Lungyen Life Service (5530)?
The net margin of Lungyen Life Service is 37.4% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Lungyen Life Service (5530)?
The return on equity (ROE) of Lungyen Life Service is 4.9% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Lungyen Life Service (5530)?
On an EBIT basis the return on assets of Lungyen Life Service is 1.6% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Lungyen Life Service (5530)?
The operating margin of Lungyen Life Service is 20.2% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Lungyen Life Service (5530)?
Revenue at Lungyen Life Service is growing −16.1% versus a year earlier (3y avg +0.7%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Lungyen Life Service (5530)?
Earnings per share at Lungyen Life Service are growing +356% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Lungyen Life Service (5530) generate?
The free cash flow of Lungyen Life Service is −1.1B TWD (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Lungyen Life Service (5530) carry?
The net debt of Lungyen Life Service is 2.9B TWD (fiscal year 2025). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Lungyen Life Service in the live analysis
One click puts Lungyen Life Service on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Some data
Nov 5, 2026